Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study

medRxiv(2023)10.1101/2023.01.16.23284635Source: DataRank Database

Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study is a research paper published in medRxiv (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (26)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Kimberly Tang ORCID,Guihong Wan ORCID,Nga Nguyen ORCID,Chenyue Lu ORCID,Pearl Ugwu‐Dike ORCID

Live enrichment

PubMed:36711758 OpenAlex:https://openalex.org/W4317241342

National Institutes of Health

Grant: 1K23AR077073-01A1

Racial Differences in Biomarkers and Therapeutic Targets for Chronic Itch

National Institutes of Health

Grant: 5U54CA225088-05

Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs

National Institutes of Health

Grant: 5R35GM142879-04

Robust, Generalizable, and Fair Machine Learning Models for Biomedicine

greenLicense: Elsevier TDM

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2023/01/18/2023.01.16.23284635.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.01.16.23284635

repositoryhttp://dx.doi.org/10.1101/2023.01.16.23284635

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36711758

Fields of Study

Cancer Immunotherapy and BiomarkersColorectal Cancer Treatments and StudiesNonmelanoma Skin Cancer Studies03 medical and health sciences0302 clinical medicine

Keywords

MedicineProportional hazards modelRashInternal medicineAdverse effectCancerCohortOncologyImmune checkpointImmune systemVitiligoSkin cancerDermatologyImmunologyImmunotherapyCohort StudiesHumansExanthemaImmune Checkpoint InhibitorsMelanomaRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being